J. Robyn

发表

Postsurgical management of differentiated thyroid carcinoma.

E. Mazzaferri, J. Robyn, 1996, Otolaryngologic clinics of North America.

Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome.

D. Metcalfe, T. Nutman, C. Dunbar, 2004, Blood.

Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing.

M. Fay, Weiming Fu, T. Nutman, 2007, Blood.

Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis.

D. Metcalfe, G. Shapiro, P. Bressler, 2007, The Journal of allergy and clinical immunology.

Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis

D. Maric, D. Metcalfe, O. Simakova, 2011, Haematologica.

KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities.

M. Fay, L. Scott, Weiming Fu, 2007, The Journal of allergy and clinical immunology.

Imatinib-Responsive Hypereosinophilia in a Patient with B Cell ALL

D. Arthur, T. Nutman, C. Dunbar, 2004, Leukemia & lymphoma.

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome.

N. Young, A. Barrett, J. Maciejewski, 2002, Blood.

A pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis

A. Barrett, D. Metcalfe, R. Childs, 2006, Bone Marrow Transplantation.

Lineage Analysis of the FIPL1-PDGFRα Fusion Gene in Myeloproliferative Hypereosinophilic Syndrome.

J. P. McCoy, T. Nutman, C. Dunbar, 2004 .

Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusion

P. Marynen, D. Arthur, I. Lahortiga, 2008, Haematologica.

Systemic mastocytosis.

D. Metcalfe, C. Akin, J. Robyn, 2004, Annual review of medicine.

Imatinib-responsive hypereosinophilic syndrome.

J. Robyn, 2006, Leukemia research.

Cranial sinus thrombosis and preeclampsia.

C. A. Koch, J. Robyn, E. Walz, 1997, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria

M. Triggiani, A. Órfão, H. Kluin-Nelemans, 2007, European journal of clinical investigation.

Exposure to domestic cats: risk factor for Pasteurella multocida peritonitis in liver cirrhosis?

S. Koletar, C. A. Koch, C. Mabee, 1996, The American journal of gastroenterology.

Multilineage involvement of the fusion gene in patients with FIP1L1/PDGFRA‐positive hypereosinophilic syndrome

T. Nutman, C. Dunbar, S. Pack, 2006, British journal of haematology.

Treatment of systemic mastocytosis.

D. Metcalfe, T. Wilson, J. Robyn, 2006, Immunology and allergy clinics of North America.

Can the long-term prognosis of patients with seizures and structural brain lesions be improved by surgical treatment?

J. Robyn, C. A. Koch, 1999, Seizure.

Diverse realities and policy portrayals : what teacher experiences bring to the antiracism policy process

Hudson, J. Robyn, 2014 .

Systemic lupus erythematosus: a risk factor for pneumonia caused by Legionella micdadei?

J. Robyn, M. Coccia, C. Koch, 1997, Archives of internal medicine.

How do levels of (endogenous) glucocorticoids, interleukin‐10 and interleukin‐12 relate to multiple sclerosis relapse before, during and after pregnancy?

K. Pacak, J. Robyn, C. Koch, 1999, Clinical endocrinology.

Risk of animal contact in immunocompromised hosts.

J. Robyn, C. Koch, 1998, Archives of internal medicine.